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An Activated Form of Notch Influences
the Choice between CD4 and CD8 T Cell Lineages
Ellen Robey,* David Chang,* Andrea Itano,* Consistent with this possibility, alterations in Notch
Dragana Cado,* Heather Alexander,* Deborah Lans,* function in vertebrates lead to developmental abnormal-
Gerry Weinmaster,† and Patrick Salmon* ities (Jhappan et al., 1992; Coffman et al., 1993; Swiatek
*Department of Molecular and Cell Biology et al., 1994; Austin et al., 1995; Conlon et al., 1995) and
University of California cancer (Ellisen et al., 1991; Robbins et al., 1992; Pear
Berkeley, California 94720 et al., 1996). From these studies, however, there is no
†Department of Biological Chemistry clear indication whether Notch affects the choice be-
School of Medicine tween alternative cell fates, as it does in invertebrates.
Molecular Biology Institute In particular, while increased Notch activity reduces the
University of California number of cells that adopt a neuronal fate (Coffman et
Los Angeles, California 90024 al., 1993; Austin et al., 1995), it is not clear whether the
cells that received a Notch signal adopted alternative
fates or simply failed to mature. In addition, these experi-
Summary ments do not provide any information about how Notch
signals integrate with other developmental cues. Thus
Notch is a transmembrane receptor that controls cell the issue of how Notch functions in vertebrates is still
fate decisions in Drosophila and whose role in mam- poorly understood.
malian cell fate decisions is beginning to be explored. We have begun to investigate the role of Notch in a
We are investigating the role of Notch in a well-studied well-studied mammalian cell fate decision: the choice
mammalian cell fate decision: the choice between the between the CD4 and CD8 T cell lineages. In the thymus,
CD8 and CD4 T cell lineages. Here we report that ex- developing T cells rearrange and express their T cell
pression of an activated form of Notch1 in developing antigen receptor (TCR) genes and undergo a testing
T cells of the mouse leads to both an increase in CD8 process based on the ability of their TCRs to recognize
lineage T cells and a decrease in CD4 lineage T cells. major histocompatability complex (MHC) proteins ex-
Expression of activated Notch permits the develop- pressed on thymic epithelial cells (reviewed in Robey
ment of mature CD8 lineage thymocytes even in the and Fowlkes, 1994; Jameson et al., 1995). The interac-
absence of class I major histocompatability complex tion between developing thymocytes and thymic epithe-
(MHC) proteins, ligands that are normally required for lial cells promotes the survival of thymocytes and also
the development of these cells. However, activated directs their lineage choice. Thymocytes whose TCRs
Notch is not sufficient to promote CD8 cell develop- recognize class I MHC expressed on thymic epithelial
ment when both class I and class II MHC are absent. cells develop as CD8 cells, whereas thymocytes whose
These results implicate Notch as a participant in the
antigen receptors recognize class II MHC proteins de-
CD4 versus CD8 lineage decision.
velop as CD4 cells. While it is clear that MHC recognition
influences the choice between theCD4 and CD8 lineage,
Introduction the mechanistic basis for this influence is not known.
The Notch1 gene is expressed in developing thymo-
Cell–cell interactions play a crucial role in specifying cell cytes (Weinmaster et al., 1991, 1992; Hasserjian et al.,
fate duringdevelopment. In the Drosophila embryo, cells 1996), raising the possibility that Notch might also play
are specified to become either neuronal or epidermal a role in the CD4 versus CD8 lineage decision. We de-
through interactions between neighboring cells. The
cided to investigate this possibility by examining the
transmembrane protein Notch is the receptor for a signal
effect of a constitutively activated form of Notch on
that diverts cells from adopting a primary, neuronal fate
thymic development in the mouse. We find that expres-and directs them toward a secondary, epidermal fate
sion of an activated form of Notch during thymic devel-instead. In Drosophila embryos that lack Notch function,
opment biases the CD4/CD8 lineage decision in such aall precursor cells become neuronal, whereas in em-
way that the development of CD8 T cells is favored overbryos with a gain-of-function Notch mutation, extra epi-
the development of CD4 T cells. In addition, activateddermal cells appear at the expense of neurons (reviewed
Notch permits the development of CD8 lineage cells inin Greenwald and Rubin, 1992; Artavanis-Tsakonas et
the absence of class I MHC, a ligand that is normallyal., 1995; Simpson, 1995). Although the role of Notch has
required for CD8 cell development. However, activatedbeen most extensively studied in the nervous system,
Notch is not sufficient to promote CD8 cell developmentNotch is expressed throughout Drosophila development
when both class I and class II MHC are absent. Theseand is involved in cell fate decisions in many different
results indicate that theNotch signaling pathway partici-tissues.
pates in the CD4 versus CD8 lineage decision. In addi-Notch homologs have been identified in vertebrates,
tion, these results imply two distinct roles for MHC rec-and thehigh degree of similarity in amino-acidsequence
ognition in the development of CD4 and CD8 T cells:suggests a conserved role for Notch in vertebrate devel-
one that renders a thymocyte competent to respond toopment (Coffman et al., 1990; Weinmaster et al., 1991;
the Notch signal, and a second that acts together withdel Amo et al., 1992; Stifani et al., 1992; Weinmaster et
al., 1992; Lardelli and Lendahl, 1993; Lardelli et al., 1994). Notch to direct the CD4 versus CD8 lineage decision.
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Figure 1. Expression of an Activated Notch
Transgene and Endogenous Notch1 in Thy-
mocytes
(a) Expression of the activated form of Notch
(NotchIC) in thymocytes from transgenic
mice. The transgenic construct used in this
study consists of a portion of the Notch intra-
cellular domain extending from amino acid
1750 to 2293, fused to an N terminal FLAG
antibody epitope tag, under the control of the
murine Lck proximal promoter (Chaffin et al.,
1990; Abraham et al., 1991). This promoter
directs high level, thymocyte-specific ex-
pression of heterologous coding regions in
transgenic mice (Sentman et al., 1991; Teh et
al., 1991). Immunoblot analysis using an anti-
FLAG antibody of whole cell lysates (107 cell
equivalents/lane) from thymocytes obtained
from two transgenic mouse lines (NotchIC-5
and NotchIC-9) and their nontransgenic lit-
termates. The positions of molecular-weight
markers are indicated. A band corresponding
to the approximate size of activated Notch is
present in extracts from transgenic mice but
not in extracts from nontransgenic mice. (b–h)
Expression of endogenous Notch1 in thymo-
cytes from wild-type mice. The Notch1 anti-
sera was raised against a portion of the ex-
tracellular domain of Notch (amino acids
381–853) that is not included in the NotchIC
transgene. (c and f) Class II MHC mutant mice
(d and g) and NotchIC-9 transgenic mice (e
and h) were doubly stained for expression
of endogenous Notch1 (c–e) and CD4 (f–h).
Control staining of wild-type thymocytes with
an anti-GST antisera is also shown (b). Verti-
cal panels depict the same field of cells.
Results 1993; Struhl et al., 1993). In these experiments, expres-
sion of the intracellular domain of either lin-12 or glp-1
leads to distinct cell fate transformations that are oppo-Transgenic Mice Expressing an Activated
Form of Notch in Developing T Cells site to those observed with loss-of-function mutations.
To investigate the role of Notch in T cell fate decisions,Previous studies in invertebrates have established that
truncated forms of Notch consisting of its isolated intra- we therefore generated transgenic mice expressing the
analogous activated form of Notch in developing thymo-cellular domain act as constitutively activated versions
of the receptor and produce gain-of-function pheno- cytes.
In order to express activated Notch in developing thy-types when expressed during development (Lieber et
al., 1993; Rebay et al., 1993; Roehl and Kimble, 1993; mocytes, we first isolated the Notch1 cDNA from a
mouse thymocyte cDNA library using a probe from theStruhl et al., 1993; Diaz-Benjumea and Cohen, 1995).
For example, expression of the intracellular domain of rat Notch1 gene (Weinmaster et al., 1991). We then gen-
erated a transgenic construct containing the intracellu-Notch during Drosophila development under the control
of a heat shock promoter leads to the development of lar domain of the murine Notch1 gene fused to a FLAG
epitope tag, under the control of the thymocyte-specificextra epidermal cells at the expense of neurons in both
the embryonic central nervous system and the adult Lck proximal promoter (Chaffin et al., 1990), and used
this construct to generate transgenic mice. Anti-FLAGperipheral nervous systems. These are the opposite
phenotypes of those observed with loss-of-function mu- Western blot analysis of thymocyte extracts from two
independent transgenic lines reveals the presence of atations of Notch (Lieber et al., 1993; Rebay et al., 1993;
Struhl et al., 1993). Expressionof the intracellular domain band corresponding to the approximate predicted size
of activated Notch (Figure 1a).of Notch during wing development in Drosophila leads
to the induction of wingless expression and the produc-
tion of an ectopic wing margin, whereas loss-of-function
mutations of Notch result in the loss of wingless expres- Expression of Endogenous Notch in Thymocytes
from Wild-Type Mice and from Mice Expressingsion and reduced growth at the wing margin (Diaz-Ben-
jumea and Cohen,1995). Similar observations have been an Activated Form of Notch
Previous studies indicate that Notch1 mRNA is ex-made in C. elegans using truncated versions of the re-
lated receptors, lin-12 and glp-1 (Roehl and Kimble, pressed in the developing thymus (Weinmaster et al.,
Notch and the CD4 versus CD8 Lineage Decision
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Figure 2. More CD8 Lineage Thymocytes in
Mice Expressing an Activated Form of Notch
(a) The percentage of mature CD4 and CD8
lineage thymocytes in two lines of mice bear-
ing the activated Notch transgene. Thymo-
cytes from 4- to 12-week-old transgenic mice
or nontransgenic littermates were analyzed
for expression of CD4, CD8, and TCR. The
gating of three parameter flow cytometric
data was performed as shown in Figure 4.
Mature CD4 lineage thymocytes are CD41
CD82TCRhigh, and mature CD8 lineage thymo-
cytes are CD42CD81TCRhigh. Bars are the av-
erage of the percentage in each population,
and superimposed dots are values from indi-
vidual mice. (b) Relative number of thymo-
cytes in NotchIC transgenic mice. The total
number of thymocytes from each mouse is
normalized to the average of the non-
transgenic littermates analyzed on the same
day.
1991, 1992; Hasserjian et al., 1996). To confirm the pres- activated Notch affects this cell fate decision, we exam-
ined thymocytes from Notch transgenic mice for expres-ence of Notch1 protein in thymocytes and to examine
the effect of activated Notch on endogenous Notch1 sion of CD4, CD8, and TCR. In normal mice, the majority
of thymocytes are immature cells that express both CD4expression, we examined thymocytes from nontrans-
genic and NotchIC transgenic mice by immunofloures- and CD8 coreceptors and low levels of TCR. Mature
CD4 and CD8 lineage thymocytes can be identified bycence, using antisera raised against a portion of the
extracellular domain of Notch1. Thymocytes from wild- expression of high levels of TCR and exclusive expres-
sion of either CD4 or CD8. We find that thymocytestype mice have a fraction of cells that stain brightly with
anti-Notch1 antisera (Figure 1c), a subset of which also from mice expressing the activated Notch transgene
(NotchIC transgenic) have a 10-fold increase in the per-expresses CD4 (Figure 1f). Mice that are deficient for
class II MHC proteins also have a subset of thymocytes centage of mature CD8 lineage thymocytes compared
to their nontransgenic littermates (Figure 2a). Expres-that express both Notch1 and CD4 (Figures 1d and 1g).
Because class II MHC mutant mice lack mature CD4 sion of the activated Notch transgene does not cause
any significant alteration in the total number of thymo-lineage thymocytes, this indicates that some of the cells
that stain brightly with the anti-Notch1 antisera are cytes, most of which are immature CD41CD81 cells (Fig-
ure 2b). Thus there is an z10-fold increase in both theCD41CD81. In addition to the brightly staining cells, the
majority of thymocytes from B6 and class II MHC mutant absolute number and the percentage of mature CD8
lineage thymocytes in NotchIC-9 transgenic mice. Themice display a lower level of staining with the anti-
Notch1 antisera that is significantly higher than the severity of the phenotype observed correlates with the
level of expression of the activated Notch protein. Thebackground observed with a control anti-GST rabbit
antisera (Figures 1b–1d). This is consistent with previous NotchIC-5 line, which expresses lower levels of acti-
vated Notch than the NotchIC-9 line (Figure 1a), showsflow cytometric analysis of Notch1 in thymocytes indi-
cating that CD42CD82 cells stain brightly for Notch1, a more modest increase (2.6-fold) in CD8 cells (Figure
2a). These results indicate that activated Notch favorswhereas CD41CD81 thymocytes display lower butsignfi-
cant expression of Notch1 (Hasserjian et al.,1996). Inter- the development of CD8 lineage T cells.
estingly, the staining on the majority of thymocytes is
elevated in NotchIC transgenic mice (Figure 1e). Be- Reciprocal Changes in the Production Rate of CD4
and CD8 T Cells in Mice Expressingcause the antibody is directed against a portion of the
extracellular domain of Notch1 and the transgene con- Activated Notch
In invertebrates, Notch and the related receptors lin-12sists of a portion of the intracellular domain, this in-
creased staining reflects an increase in endogenous and glp-1 often control the choice between alternative
cell fates. Since CD4 and CD8 lineage cells derive fromNotch1 protein in response to activated Notch. This sug-
gests that Notch1 protein levels may be regulated by a common thymic precursor, it was surprising to see
an increase in CD8 lineage thymocytes in NotchICNotch signaling in thymocytes, a phenomenon that has
been previously described for the Notch-like receptor transgenic mice without a consistent decrease in CD4
lineage cells. However, thymic development in the adultlin-12 in C. elegans (Wilkinson et al., 1994).
mouse is a dynamic process, and the steady-state size
of the thymic populations is determined by several fac-Activated Notch Leads to an Increased Number
of Mature CD8 Lineage Thymocytes tors, including the rate at which cells are generated, the
rate at which they die, and the rate at which they emi-During thymic development, uncommitted T cell precur-
sors give rise to the two major mature T cell lineages, grate from the thymus. The steady-state size of the ma-
ture CD4 and CD8 populations in the thymus, therefore,CD4 T cells and CD8 T cells. To determine whether
Cell
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Figure 3. Kinetics of Appearance of Mature CD4 and CD8 Lineage Thymocytes in Mice Expressing the Activated Notch Transgene
Mice were continuously exposed to the thymidine analog bromodeoxyuridine (BrdU) in their drinking water for the indicated times. Thymocytes
were then analyzed for BrdU content and for the expression of CD4, CD8, and abTCR using four parameter flow cytometry, as described in
Experimental Procedures. (a) Representative FACS plots for nontransgenic and NotchIC9 transgenic mice after 7 days of continuous BrdU
labeling. The gates used to define the cell populations are indicated. (b) Turnover of CD41CD81 thymocytes. The percentage of CD41CD81
that are labeled with BrdU is plotted as a function of labeling time. (c) Time course of the appearance of mature labeled thymocytes from
NotchIC transgenic mice (closed circles) or nontransgenic mice (open circles). Mature thymocytes are defined as TCRhigh and either CD41CD82
or CD42CD81. The absolute number of mature labeled thymocytes of each type is plotted against the time of continuous exposure to BrdU.
The rate of mature thymocyte production (calculated from a least squares fit of the data) is 2.9 3 106 cells/day for wild-type (R value 5 0.86)
and 2.4 3 106 cells/day for NotchIC transgenic mice (R value 5 0.59). (d and e) Time course of the appearance of TCRhigh, Brdu1 cells that
are either CD41CD82 (closed circles) or CD42CD81 (open circles). The absolute number of mature labeled thymocytes of each type is plotted
against the time of continuous exposure to BrdU. The slopes of the lines are: nontransgenic CD4 cells, 2.2 3 106 cells/day (R value 5 0.86);
nontransgenic CD8 cells 0.74 3 106 cells/day (R value 5 0.80); NotchIC transgenic CD4 cells, 0.47 3 106 cells/day (R value 5 0.58); NotchIC
transgenic CD8 cells 2.0 3 106 cells/day (R value 5 0.54).
provides only an indirect indication of how many cells indicates that activated Notch does not affect the prolif-
eration or life span of immature CD41CD81 thymocytes.are choosing a particular fate.
To obtain a more direct measure of the effect of acti- The majority of CD41CD81 thymocytes die in the thy-
mus, but a small fraction develop into long-lived maturevated Notch on the CD4/CD8 lineage choice, we mea-
sured the kinetics of the appearance of mature thymo- thymocytes (TCRhighCD41CD82 or TCRhighCD42CD81). In
contrast to CD41CD81 thymocytes, the mature thymiccytes in NotchIC transgenic mice, using the thymidine
analog bromodeoxyuridine (BrdU). We exposed populations are not dividing, and this is reflected in
the 1–2-day lag in the appearance of BrdU in theseNotchIC-9 transgenic and nontransgenic littermates to
BrdU in their drinking water for various time periods and populations (Figures 3c–3e and Egerton et al., 1990).
Importantly, this lag in the labeling of mature thymocytesthen analyzed thymocytes for the presence of BrdU and
for the expression of CD4, CD8, and TCR (Figure 3). is observed in both wild-type and NotchIC transgenic
mice. This indicates that activated Notch does not leadBrdU is incorporated in the DNA of dividing cells and
can be detected using a monoclonal antibody. In wild- to the inappropriate proliferation of mature thymocytes.
Because mature thymocytes are not proliferating, thetype mice, CD41CD81 thymocytes are short-lived cells
that are proliferating or are the immediate products of rate of appearance of BrdU labels in these populations
reflects the fraction of CD41CD81 precursors that de-proliferating cells. Thus CD41CD81 thymocytes label
rapidly with BrdU, and almost all are BrdU1 after 3–4 velop into mature thymocytes. The rate of appearance
of labeled mature thymocytes (BrdU1TCRhigh and eitherdays of continuous labeling (Figure 3b). Importantly, the
turnover of CD41CD81 thymocytes is virtually identical CD41CD82 or CD42CD81) is similar in wild-type and
NotchIC transgenic mice (Figure 3c). This indicates thatin NotchIC transgenic mice and wild-type mice. This
Notch and the CD4 versus CD8 Lineage Decision
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activated Notch does not significantly alter the fraction CD81, TCRhigh, and HSAlow (Figure 4a). Mice that express
the NotchIC transgene have z10-fold more CD42CD81of thymocytes that develop into long-lived mature T
cells. In contrast, the relative proportion of cells that thymocytes (Figures 2a, 4b, and 4e), and the majority
of these cells express high levels of TCR and low levelsdevelop as mature CD4 or CD8 lineage cells is dramati-
cally affected by activated Notch (Figures 3d and 3e). of HSA (Figure 4b). In homozygous b2-microglobulin
mutant mice, which are deficient for class I MHC, thereNotchIC transgenic mice have an z3-fold increase in
the rate of CD8 cell production as well as an z5-fold are some CD42CD81 thymocytes, but these cells ex-
press low levels of TCR and high levels of HSA, indicat-decrease in the rate of CD4 cell production, leading to
a 15-fold change in the ratio of CD4 versus CD8 cell ing that these are the immature precursors of CD41CD81
thymocytes (Figure 4c). Strikingly, in homozygous b2-production compared to wild-type. Thus expression of
an activated form of Notch in thymocytes leads to both microglobulin mutant NotchIC transgenic mice, there is
a large population of CD42CD81TCRhighHSAlow thymo-an increase in the proportion of precursor cells that give
rise to CD8 lineage cells and a decrease in the proportion cytes (Figures 4d and 4e). The mature CD8 population
in class I MHC deficient NotchIC transgenic mice isthat give rise to CD4 lineage cells. Although mature
CD4 lineage thymocytes are generated less efficiently reduced 3-fold compared to the mature CD8 population
found in NotchIC transgenic mice that express class Iin NotchIC transgenic mice compared to wild type, the
CD4 cells can sometimes accumulate to steady-state MHC, suggesting that class I MHC does contribute to the
development of the mature CD8 cells found in NotchIClevels that are comparable to those found in wild-type
mice (Figures 2a and 3a). This may reflect a homeostatic transgenic mice. Nevertheless, class I MHC deficient
NotchIC transgenic mice have 2-fold more mature CD8mechanism that regulates the steady-state numbers of
mature CD4 T cells in the thymus. Together, these data thymocytes than do wild-type mice and greater than
100-fold more than do nontransgenic mice that lackindicate that activated Notch biases the choice of
CD41CD81 cells between the CD4 and CD8 lineages in class I MHC. These results indicate that activated Notch
can drive the development of CD8 lineage thymocytes,such a way that CD8 cell development is favored and
CD4 cell development is inhibited. The involvement of even in the absence of class I MHC proteins.
Mature T cells that arise in the thymus emigrate toNotch in a binary cell fate decision in the mammalian
thymus is analogous to its well-documented role in the the peripheral lymphoid organs. To determine whether
the CD8 T cells that develop in class I MHC deficientdevelopment of Drosophila and C. elegans.
NotchIC transgenic mice can accumulate in the periph-
ery, we examined lymph-node cells for expression of
Activated Notch Permits CD8 T Cell Development TCR, CD4, and CD8 (Figure 4f). NotchIC transgenic mice
in Class I MHC Deficient Mice have z25% of the normal number of lymph-node T cells
The effect of the NotchIC transgene on the CD4/CD8 and no consistent alterations in the CD4/CD8 T cell
lineage decision implies that Notch activity favors CD8 ratios (Figure 4f and data not shown). The Lck proximal
T cell development over CD4 T cell development. How- promoter is known to be expressed at low levels in
ever, it is well known that the choice between the CD4 peripheral T cells (Chaffin et al., 1990; Teh et al., 1991).
and CD8 lineage is also controlled by binding of the The reduced frequency of T cells in the lymph node of
TCR and the CD4 and CD8 coreceptors on developing NotchIC transgenic mice may therefore be due to resid-
thymocytes to MHC proteins on thymic epithelial cells ual expression of activated Notch in mature T cells that
(reviewed in Robey and Fowlkes, 1994; Jameson et al., may interfere with their function in the periphery. In class
1995). Recognition of class I MHC by CD8 and TCR I MHC deficient mice, CD81 T cells represent <0.1% of
is required for the development of CD8 lineage cells, lymph-node cells, whereas in class I MHC deficient mice
whereas recognition of class II MHC by CD4 and TCR expressing activated Notch, CD81 T cells make up 2%
is required for CD4 cell development. This is most clearly of lymph-node cells. Thus the CD8 lineage T cells that
demonstrated by targeted gene-disruption experi- develop in NotchIC transgenic class I MHC deficient
ments. For example, mice that are deficient for class I mice can accumulate in theperiphery, albeit with a lower
MHC expression due to a targeted disruption of the b2- efficiency than CD8 T cells from wild-type mice.
microglobulin locus lack CD8 lineage T cells (Koller et
al., 1990; Zijlstra et al., 1990). Because activated Notch
favors CD8 lineage development, it is possible that acti- Activated Notch Is Not Sufficient to Permit CD8
Cell Development in the Absence of Bothvated Notch might override the normal requirement for
class I MHC and allow CD8 lineage cells to develop in Class I and Class II MHC Proteins
Thymocytes whose TCRs recognize class II MHC nor-class I MHC deficient mice.
To investigate this question, we crossed the NotchIC mally develop as CD4 lineage T cells. Because class II
MHC proteins are present in b2-microglobulin mutanttransgenic mice with b2-microglobulin mutant mice and
analyzed thymocyte populations from the littermates of mice, the CD8 cells observed in NotchIC transgenic b2-
microglobulin mutant mice could be cells with class IIthe cross for expression of CD4, CD8, and TCR (Figures
4a–4e). In this experiment, we also examined the expres- specific TCRs that developed as CD8 cells rather than
CD4 cells due to the presence of activated Notch. Tosion of the heat-stable antigen (HSA), a marker that
is high on immature thymocytes and low on mature investigate this question, we made chimeric mice using
donor hemopoetic stem cells from NotchIC transgenicthymocytes. Mice that are heterozygous for the b2-
microglobulin mutation, like wild-type mice, have a pop- mice to reconstitute irradiated host mice that were class
I MHC deficient (b2-microglobulin mutant), class II MHCulation of mature CD8 lineage thymocytes that areCD42,
Cell
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Figure 4. Activated Notch Permits the Appearance of Mature CD8 Lineage Thymocytes in the Absence of Class I MHC Proteins
Transgenic mice of the NotchIC-9 line were crossed with b22microglobulin mutant mice (Zijlstra et al., 1990), and offspring from the second
back-cross were typed for the presence of the NotchIC transgene (TG1) by dot blot hybridization and for homozygosity of the b2-microglobulin
mutation (b2M2/2) by testing peripheral blood lymphocytes for expression of class I MHC proteins Kb and Kk. Thymocytes from 4- to 12-week-
old mice from the second back-cross wereanalyzed for expression of CD4, CD8, TCR, andHSA. Representative FACS plots for (a) nontransgenic,
b2-microglobulin 1/2, (b) NotchIC-9 transgenic, b2-microglobulin 1/2, (c) nontransgenic, b2-microglobulin 2/2, and (d) NotchIC-9 transgenic,
b2-microglobulin 2/2 are shown. The numbers in the quadrants indicate the percentage of total thymocytes in each population. The dark
rectangle indicates the analysis gate used to define CD42CD81 thymocytes. The numbers over bar are the percentage of thymocytes within
the indicated gates. (e) The percentage of thymocytes that are mature CD4 or CD8 lineage thymocytes. The genotypes of the mice are
indicated. Mature CD4 lineage thymocytes are CD41CD82TCRhigh, and mature CD8 lineage thymocytes are CD42CD81TCRhigh. Bars are the
average of the percentage in each population, and superimposed dots are values from individual mice. (f) The percentage of lymph-node
cells that are mature CD41CD82 or CD42CD81. The genotypes of the mice are indicated.
deficient (Ab mutant mice [Cosgrove et al., 1991; Grusby few mature CD4 cells develop (Figure 5b) (Markowitz et
al., 1993), whereas in MHC double mutant hosts, fewet al., 1991]), or class I and class II MHC deficient (b2-
microglobulin, Ab mutantmice). As previously observed, mature T cells of either lineage are present (Figure 5c).
In contrast, a substantial population of mature CD8 thy-when wild-type thymocytes develop in class I MHC defi-
cient hosts, very few mature CD8 cells develop (Figure mocytes is present when NotchIC transgenic thymo-
cytes develop in either class I MHC deficient (Figure 5d)5a) (Bix and Raulet, 1992). This reflects the fact that
CD8 T cell development is largely dependent upon the or class II MHC deficient (Figure 5e) hosts (5.8% and
3.9% of total thymocytes, respectively). However, whenrecognition of class I MHC proteins on the radiation-
resistant thymic epithelial cells of the host. When wild- NotchIC transgenic T cells develop in hosts that lack
expression of both class I and class II MHC, very fewtype T cells develop in class II MHC mutant hosts, very
Notch and the CD4 versus CD8 Lineage Decision
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Figure 5. Either Class I or Class II MHC Is
Required for the Development of CD8 Lin-
eage T Cells in Thymocytes Expressing Acti-
vated Notch
Hemopoetic stem cells from nontransgenic
(a–c) or NotchIC-9 transgenic (d–f) mice were
used to reconstitute irradiated MHC mutant
mice. Irradiated mutant hosts were class I
deficient (a and d) (b2-microglobulin mutant
mice, Zijlstra et al., 1990), class II deficient (b
and e) (Ab mutant mice, Grusby et al., 1991),
or MHC class I and class II deficient (c and
f). After 4 weeks to allow reconstitution of the
thymus, thymocytes from radiation chimeras
were analyzed for expression of CD4, CD8,
and abTCR, as described in Experimental
Procedures. The numbers in the quadrants
indicate the percentage of total thymocytes
in each population. The dark rectangle indi-
cates the analysis gate used to define
CD42CD81 thymocytes. The numbers over
bar are the percentage of total thymocytes.
Two chimera of each type were analyzed, and
representative data are shown. The small
population of mature CD8 cells present in
wt > class I MHC deficient chimeras could be
dueto the recognition of class I MHC proteins
of the donor cells (Bix and Raulet, 1992).
mature CD8 thymocytes are observed (Figure 5f). To- In invertebrates, the role of Notch in cell fate decisions
has been well documented using conditional loss-of-gether, these results indicate that activated Notch alters
the fate of the maturing T cells but does not overcome function and gain-of-function mutations. It is important
to note that the phenotypes observed when the intracel-the requirement for MHC recognition. When Notch is
regulated normally, class I recognition leads to CD8 cell lular domain of Notch is expressed during development
correspond to the reciprocal cell fate transformationsdevelopment and class II MHC recognition leads to CD4
cell development. In contrast, in the presence of a con- to those observed with loss of function alleles in every
case described (Lieber et al., 1993; Rebay et al., 1993;stitutively activated form of Notch, recognition of either
class I or class II MHC leads to the development of CD8 Roehl and Kimble, 1993; Struhl et al., 1993; Diaz-Benju-
mea and Cohen, 1995). It is quite likely, therefore, thatlineage T cells.
the phenotype that we observe reflects a normal physio-
logical process mediated by Notch. Furthermore, theDiscussion
highly specific effect of the mutation on the CD4/CD8
cell fate decision but not on the proliferation, turnoverThe choice of uncommitted thymocytes between the
rate, or steady-state numberof thymocytesalso stronglyCD4 and CD8 T cell lineages is governed by the recogni-
suggests a specific role for the Notch signaling pathwaytion of MHC class I and class II proteins on thymic
in CD4/CD8 cell fate determination. Although ourexperi-epithelial cells, but the mechanism that drives this lin-
ments do not prove that Notch is involved in this deci-eage decision is unknown. Here we show that expres-
sion, the fact that Notch1 is expressed in developingsion of an activated form of Notch in developing T cells
thymocytes (Weinmaster et al., 1991, 1992; Hasserjianbiases the choice between the CD4 and CD8 lineages
et al., 1996; and Figure 1, here) makes this quite likely.in such a way that CD8 cell development is favored
Analysis of the effect of a Notch1 gene disruption onover CD4 cell development. When Notch is regulated
thymic development may provide a resolution of thisnormally, the recognition of class I MHC by developing
question. Because Notch1 mutant mice die around daythymocytes leads to CD8 T cell development, whereas
10 of gestation, before the formation of the thymus (Swi-class II MHC recognition leads to CD4 T cell develop-
atek et al., 1994; Conlon et al., 1995), a conditional genement. In the presence of activated Notch, however, rec-
disruption is needed to definitively assess the role ofognition of either class I or class II MHC leads to CD8
T cell development. These results show that alterations Notch1 in T cell development.
How do Notch and MHC recognition work togetherin Notch activity can affect the choice between two
alternative mature cell fates in mammals. Furthermore, to specify the CD4 and CD8 T cell fates? While we do
not yet have a complete answer, the effect of activatedthese results have important implications for under-
standing how MHC recognition influences the CD4 ver- Notch in MHC mutant mice provides an important clue.
The observation that an activated form of Notch cansus CD8 lineage choice.
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not. Another more interesting possibility is that both
Notch and the Notch ligand are expressed on thymo-
cytes, and Notch signaling between neighboring thymo-
cytes is influenced by signals through the TCR and CD4
or CD8 coreceptors upon recognition of MHC proteins
on thymic epithelial cells (Figures 6a and 6b). Recogni-
tion of class I and class II MHC generates distinct intra-
cellular signals, due in part to the participation of CD8
and CD4 (Ravichandran and Burakoff, 1994; Itano et al.,
1996). Perhaps signaling through CD4 causes a thymo-
cyte to down-regulate Notch, whereas a CD8 signal
makes a thymocyte up-regulate Notch. An initial differ-
ence in the level of Notch signaling due to class I or
class II MHC recognition might then be reinforced by a
feedback mechanism, analogous to those described in
Drosophila (Heitzler and Simpson, 1991) and C. elegans
(Wilkinson et al., 1994), wherein increased Notch signal-
ing results in up-regulation of Notch and down-regula-
tion of the Notch ligand. Indeed, the observation that
endogenous Notch1 protein is increased in the presence
of activated Notch is consistent with such a mechanism.
This model is also reminiscent of vulva development in
C. elegans, in which the choice of precursor cells be-
tween primary and secondary cell fates is determined
by the combined action of a graded inductive signal
(acting through a receptor tyrosine kinase) and a lateral
signal through the Notch-like receptor lin-12 (Beitel etFigure 6. Signal Integration in the CD4 versus CD8 Lineage De-
al., 1995; Katz et al., 1995). With the recent identificationcision
of ligands for Notch in vertebrates (Bettenhausen et al.,(a) A thymocyte that recognizes class II MHC avoids the Notch
1995; Chitnis et al., 1995; Henrique et al., 1995; Lindsellsignal. (b) A thymocyte that recognizes class I MHC receives the
Notch signal. We have depicted the ligand for Notch on a neigh- et al., 1995), soon the thymic ligand for Notch should
boring thymocyte (lateral signaling); however, an alternative possi- be identified and the manner of regulating Notch signal-
bility is that the ligand for Notch is on another cell type (inductive ing in the thymus resolved.
signaling) (Henderson, 1994). (See text for discussion.) (c) In wild-
Although activated Notch can allow thymocytes bear-type mice, in which Notch is regulated by ligand binding, recognition
ing class II specific TCRs to develop as CD8 T cells,of class II MHC allows the thymocyte to avoid the Notch signal, and
it cannot allow CD8 cell development in the completethymocytes develop as CD4 lineage T cells. In contrast, thymocytes
that recognize class I MHC proteins receive the Notch signal and absence of MHC recognition. This implies a role for MHC
develop as CD8 cells. (d) In the presence of a constitutively activated recognition that is distinct from its role in directing the
form of Notch, thymocytes that recognize class I or class II MHC CD4 versus CD8 lineage decision. The vast majority of
receive a Notch signal and develop as CD8 cells.
developing T cells die in the thymus, due in part to the
requirement for MHC recognition for thymocyte survival.
cause mature CD8 T cells to develop in class I MHC In the absence of an MHC signal, a thymocyte may not
deficient mice suggests that Notch acts downstream or survive long enough to differentiate into a CD8 cell, even
in a parallel pathway with MHC recognition to specify though it may receive a Notch signal. It is also possible
the CD8 T cell fate (Figure 6). This implies that when a that MHC recognition induces a maturation program
thymocyte recognizes a class I MHC, it results in the cell that can lead to the development of either CD4 or CD8
receiving a Notch signal. Conversely, when a thymocyte lineage cells. This program would then be influenced
recognizes class II MHC, it allows the cell to avoid the by the combined action of Notch and a specific signal
Notch signal. In the presence of a constitutively acti- through either class I or class II MHC recognition to
vated form of Notch, thymocytes that recognize class direct the developing T cell to the appropriate lineage.
II MHC can no longer avoid the Notch signal and develop
as CD8 cells.
Experimental ProceduresHow might Notch signaling be influenced by MHC
recognition? Notch is normally regulated by ligand bind-
The mouse Notch1 cDNA was isolated from a mouse thymocyte
ing, and a number of scenarios could be envisaged by cDNA library using the rat Notch1 probe (kindly provided by Gerry
which MHC recognition would determine whether or not Weinmaster; see Weinmaster et al., 1992). Partial sequence analysis
of 16 hybridizing clones indicated that they all corresponded toa thymocyte is exposed to the Notch ligand. One possi-
mouse Notch1 (del Amo et al., 1993). A synthetic linker containingbility is that there are two different types of specialized
a Kozak sequence, AUG, and a FLAG epitope was inserted beforethymic epithelial cells: those that express both class I
the NgoMI to SpeI fragment of the mouse cDNA and cloned intoMHC and the Notch ligand and those that express class
the EcoRI and SpeI sites of Bluescript. The sequence of the sense
II MHC but not the Notch ligand. Thus thymocytes that oligo is: 59-aa ttc ggt acc atg gac tac aaa gac gat gac gat aaa gc-39.
recognize class I MHC would come into contact with The anti-sense oligo is: 59- ccg ggc ttt atc gtc atc gtc ttt gta gtc
cat ggt acc g-39. The 1.7 kb EcoRI to HindIII fragment of this plasmidthe ligand and those that recognize class II MHC would
Notch and the CD4 versus CD8 Lineage Decision
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